Evidence map›Paper›PMID 30725526›Full record

ReviewAdvanced healthcare materials2019

Molecular Engineering of Functional Nucleic Acid Nanomaterials toward In Vivo Applications.

JingJing Zhang, Tian Lan, Yi Lu

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Unlocking Genetic Profiles with a Programmable DNA-Powered Decoding Circuit.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

JingJing ZhangDepartment of Chemistry, University of Illinois at Urbana-Champaign, 601 S. Mathews Ave., Urbana, IL, 61801, USA.
Tian LanGlucoSentient, Inc., 2100 S. Oak Street Suite 101, Champaign, IL, 61820, USA.
Yi LuDepartment of Chemistry, University of Illinois at Urbana-Champaign, 601 S. Mathews Ave., Urbana, IL, 61801, USA.ORCID 0000-0003-1221-6709
University of Illinois Urbana-Champaign · USGlucoSentient (United States) · US

Funding

Selection and Sensing Applications of DNAzymes Selective for Paramagnetic Metal IonsR01GM124316 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI LU, YI · 2017 to 2020
$1.4M
Novel DNAzyme sensors for lithium and sodium to understand cellular and molecular mechanisms of lithium treatment of bipolar disorderR21MH110975 · NIMH · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI LU, YI · 2016 to 2017
$401k
Developing an Affordable and Pocketable POC Device for Monitoring Lithium and Sodium in Patients with Bipolar DisorderR41MH111337 · NIMH · GLUCOSENTIENT, INC. · PI LAN, TIAN · 2016 to 2016
$211k
NIGMS NIH HHS R01 GM124316NIMH NIH HHS R21 MH110975NIMH NIH HHS R41 MH111337
6 · The paper itself

Abstract

Recent advances in nanotechnology and engineering have generated many nanomaterials with unique physical and chemical properties. Over the past decade, numerous nanomaterials are introduced into many research areas, such as sensors for environmental monitoring, food safety, point-of-care diagnostics, and as transducers for solar energy transfer. Meanwhile, functional nucleic acids (FNAs), including nucleic acid enzymes, aptamers, and aptazymes, have attracted major attention from the biomedical community due to their unique target recognition and catalytic properties. Benefiting from the recent progress of molecular engineering strategies, the physicochemical properties of nanomaterials are endowed by the target recognition and catalytic activity of FNAs in the presence of a target analyte, resulting in numerous smart nanoprobes for diverse applications including intracellular imaging, drug delivery, in vivo imaging, and tumor therapy. This progress report focuses on the recent advances in designing and engineering FNA-based nanomaterials, highlighting the functional outcomes toward in vivo applications. The challenges and opportunities for the future translation of FNA-based nanomaterials into clinical applications are also discussed.

Indexed as

AnimalsAptamers, NucleotideDNA, CatalyticHumansNanostructuresNanotubes, CarbonNucleic AcidsOptical ImagingAptamers, NucleotideDNA, CatalyticNanotubes, CarbonNucleic AcidsaptamersDNAzymefunctional nucleic acidin vivo applicationsnanomaterials

Identifiers

PMID30725526
PMCPMC6426685
OpenAlexW2911426603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.